-
1 . Academic Journal
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
- 저자
- by Abadie-Lacourtoisie, Sophie; Andreetta, Claudia; Anzizar, Nerea; Aoki, Daiseuke; Barretina-Ginesta, Maria-Pilar, et al.
- 소스
- In The Lancet 6-12 January 2024 403(10421):31-43
-
7 . Periodical
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
- 저자
- by Oaknin, Ana; Gladieff, Laurence; Martínez-García, Jerónimo; Villacampa, Guillermo; Takekuma, Munetaka, et al.
- 소스
- The Lancet; January 2024, Vol. 403 Issue: 10421 p31-43, 13p